Ethical Issues in New Uses of Preimplantation Genetic Diagnosis
By Edgar Dahl,
Human Reproduction
| 06. 01. 2003
Vol.18, No. 7
[Editor's note: In this brief article,
German bioethicist Edgar Dahl raises and dismisses five objections
to the future use of embryo screening to choose the sexual orientation
of children. He does not mention any evidence for, or controversy
about, a "gay gene," but concludes that if a "safe
and reliable genetic test" for sexual orientation were
to become available, "parents should clearly be allowed"
to use it, as long as they are permitted to select for homosexual
as well as heterosexual children. Dahl has previously argued
that PGD should be allowed for sex selection for social reasons.]
Should parents be allowed to use preimplantation
genetic diagnosis to choose the sexual orientation of their
children?
Extending the application of preimplantation genetic
diagnosis (PGD) to screen embryos for non-medical traits such
as gender, height and intelligence, raises serious moral, legal,
and social issues. In this paper I consider the possibility
of using PGD to select the sexual orientation of offspring.
After considering five potential objections, I conclude that
parents should be permitted to use PGD to choose...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...